Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Ipamorelin vs GHRP-6: Differences & Which Is Better (2026)

Home/Compare/Ipamorelin vs GHRP-6 Reviewed Mar 2026 | PubMed sources Active Market This comparison can feed directly into US-first legal, provider, and cost workflows. Ipamorelin vs GHRP-6: Head-to-Head Comparison Ipamorelin offers clean, selective GH release without hunger or cortisol spikes, while GHRP-6 is known for causing intense hunger due to strong ghrelin activity. GHRP-6 was one of the earliest GHRPs studied and remains popular for those who want appetite stimulation alongside GH release. Side-by-Side Comparison Dimension Ipamorelin GHRP-6 Evidence Level Phase II trials Extensive preclinical and clinical research FDA Status Not approved Not approved GH Release Potency Moderate Moderate to strong Side Effects Minimal; very selective Strong hunger, cortisol and prolactin increase, possible dizziness Appetite Stimulation Negligible Very strong (ghrelin-mediated) Mechanism Selective GHS-R1a agonist Non-selective GHS-R1a agonist with strong ghrelin mimetic activity Cost Moderate Lo

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Home/Compare/Ipamorelin vs GHRP-6

Reviewed Mar 2026 | PubMed sources

Active Market

This comparison can feed directly into US-first legal, provider, and cost workflows.

Ipamorelin vs GHRP-6: Head-to-Head Comparison

Ipamorelin offers clean, selective GH release without hunger or cortisol spikes, while GHRP-6 is known for causing intense hunger due to strong ghrelin activity. GHRP-6 was one of the earliest GHRPs studied and remains popular for those who want appetite stimulation alongside GH release.

Side-by-Side Comparison

Dimension Ipamorelin GHRP-6 Evidence Level Phase II trials Extensive preclinical and clinical research FDA Status Not approved Not approved GH Release Potency Moderate Moderate to strong Side Effects Minimal; very selective Strong hunger, cortisol and prolactin increase, possible dizziness Appetite Stimulation Negligible Very strong (ghrelin-mediated) Mechanism Selective GHS-R1a agonist Non-selective GHS-R1a agonist with strong ghrelin mimetic activity Cost Moderate Low

Evidence Level

Ipamorelin

Phase II trials

GHRP-6

Extensive preclinical and clinical research

FDA Status

Ipamorelin

Not approved

GHRP-6

Not approved

GH Release Potency

Ipamorelin

Moderate

GHRP-6

Moderate to strong

Side Effects

Ipamorelin

Minimal; very selective

GHRP-6

Strong hunger, cortisol and prolactin increase, possible dizziness

Appetite Stimulation

Ipamorelin

Negligible

GHRP-6

Very strong (ghrelin-mediated)

Mechanism

Ipamorelin

Selective GHS-R1a agonist

GHRP-6

Non-selective GHS-R1a agonist with strong ghrelin mimetic activity

Cost

Ipamorelin

Moderate

GHRP-6

Low

Peptide Overviews

Ipamorelin

BHuman Studies

Ipamorelin is a selective growth hormone secretagogue that stimulates growth hormone release from the pituitary gland without significantly affecting cortisol or prolactin levels.

Growth Hormone SecretagoguesNot Approved

View full Ipamorelin profile →

GHRP-6

BHuman Studies

GHRP-6 was one of the first synthetic GH secretagogues developed. It stimulates strong GH release but also significantly increases appetite through ghrelin receptor activation.

Growth Hormone SecretagoguesNot Approved

View full GHRP-6 profile →

Supplies for Both

Common research handling and preparation supplies for injectable peptide workflows.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Recommended Reading

Books covering peptide science, longevity research, and biohacking frameworks.

Amazon affiliate links; we may earn a small commission at no extra cost to you. See our disclosure.

Stay informed on peptide comparisons

Get weekly comparison updates, new study alerts, and regulatory changes.

No spam. Unsubscribe anytime.

Connected topics

Follow this recovery question